Phase 3 Osteoporosis Clinical Trials
7 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®
Postmenopausal Women With Osteoporosis at High Risk of Fracture
Qilu Pharmaceutical Co., Ltd.278 enrolled1 locationNCT07062978
Recruiting
Phase 3
EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy
OsteoporosisHypomagnesemia
University of Texas Southwestern Medical Center56 enrolled2 locationsNCT05998863
Recruiting
Phase 3
A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With Osteoporosis
Postmenopausal Women Osteoporosis
Mabwell (Shanghai) Bioscience Co., Ltd.278 enrolled1 locationNCT06804590
Recruiting
Phase 3
Preventing Osteoporosis in Patients with Spinal Cord Injury (SCI)
Spinal Cord Injury (SCI)Osteoporosis
Northern Sydney Local Health District - Royal North Shore Hospital100 enrolled1 locationACTRN12618000915257
Completed
Phase 3
A randomised, double-blind, placebo controlled trial to examine the effects of total oestradiol depletion on bone microstructure and the efficacy of denosumab in preventing microstructural bone decay in premenopausal women with early breast cancer
premenopausal osteoporosis
Professor Mathis Grossmann114 enrolled1 locationACTRN12616001051437
Active
Phase 3Phase 4
Vitamin D Intervention To Prevent Falls and Fractures and To Promote Mental Well-Being.
Osteoporosis and fracturesFalls prevention
The University of Melbourne2,300 enrolled1 locationACTRN12605000658617
Completed
Phase 3
ANZ 02P2 / International Breast cancer Intervention Study: IBIS-II Bone Sub-Protocol
Bone fracturesOsteoporosisOsteopenia+1 more
Australia and New Zealand Breast Cancer Trials Group1,000 enrolled1 locationACTRN12605000222640